MannKind (NASDAQ: MNKD) Afrezza weekly prescriptions were 217, up 21% week-over-week, according to RBC analyst Adnan Butt ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE